Champions Oncology, Inc.
CSBR
$7.49
-$0.68-8.32%
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.43M | -598.00K | -3.40M | -7.28M | -9.73M |
| Total Depreciation and Amortization | 1.70M | 1.79M | 1.87M | 1.87M | 1.83M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 159.00K |
| Total Other Non-Cash Items | 2.15M | 2.39M | 2.72M | 3.10M | 3.29M |
| Change in Net Operating Assets | -11.58M | -6.28M | -3.03M | -3.82M | -572.00K |
| Cash from Operations | -1.30M | -2.71M | -1.84M | -6.14M | -5.01M |
| Capital Expenditure | -25.00K | -75.00K | -60.00K | -728.00K | -1.60M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25.00K | -75.00K | -60.00K | -728.00K | -1.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -258.00K | -254.00K | -291.00K | -254.00K | -108.00K |
| Issuance of Common Stock | 315.00K | 277.00K | 241.00K | 253.00K | 252.00K |
| Repurchase of Common Stock | 0.00 | 0.00 | -32.00K | -634.00K | -709.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 57.00K | 23.00K | -82.00K | -635.00K | -565.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.27M | -2.76M | -1.98M | -7.50M | -7.18M |
